The risk is obvious. Justin Verlander turns 40 years old in February, and even for a pitcher with a long track record of remarkable durability, advanced baseball age lurks as an inevitable foe of sorts for which there is no sure-fire safeguard.
Max Scherzer is Exhibit A. Either he was limited last October by the effects of his oblique injury, which I believe, or he suddenly got old at the very worst time and there went the Mets’ grand plan for winning a championship.
Now in the wake of Jacob deGrom’s departure, Steve Cohen is doubling down on the gamble that two old pitchers, even the greatest of their generation, can be healthy and effective after six months of a regular season and get the Mets to the finish line.
Was it the right move? I asked several major-league scouts and talent evaluators that question on Monday, after Cohen agreed to pay Verlander $86 million over the next two years -- exactly what he’s paying Scherzer. And the unanimous answer was yes, largely because there really is no other way for a franchise committed to winning a championship as soon as possible.
“They really had no choice,” is the way one scout put it. “They’ve got an old roster, starting with Scherzer, and they have no high-end pitching coming out of their minor-league system for at least a couple of years.
“Cohen wants to win now and there’s no way to do it without paying top dollar for pitching. So you replace deGrom with Verlander and take another shot. If he and Scherzer are healthy for the postseason you’ve got a legitimate chance. The only other option was to sign (Carlos) Rodon, and to me, even though he’s younger, he’s a bigger risk because of his injury history.”
That was the most significant consensus opinion from the people I spoke to, including someone in Mets’ organization: that Verlander is a better bet than Rodon, based on history of injury and the length of the contract.
“Verlander is just a beast,” a second scout said. “He was never hurt until his late 30s, and then he bounces back from Tommy John (surgery) to win the Cy Young Award at age 39? You can’t overstate how impressive that is or what it tells you about his durability.
“He’s an outlier in that respect. I’d take him over Rodon, who’s had a history of arm injuries that goes back a long way. That history, for me, is more significant than the difference in age.”